Literature DB >> 869958

Relation between HLA-B27 and clinical features in patients with yersinia arthritis.

O Laitinen, M Leirisalo, G Skylv.   

Abstract

A study of 74 yersinia arthritis patients implied that the clinical picture of the disease may be modified by genetic background associated with the histocompatibility antigen B27 (HLA-B27). Sixty-six percent of patients were B27 positive. Joint symptoms were somewhat more severe in B27+ patients. Iritis, conjunctivitis, carditis, signs of urologic inflammation, and complete Reiter's triad occurred only in the B27 + group, whereas erythema nodosum was more common in B27 - group. Several B27 + patients also had "B27 + rheumatic diseases," such as ankylosing spondylitis or Reiter's disease, in their history.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 869958     DOI: 10.1002/art.1780200512

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  17 in total

1.  Late complications after a Yersinia enterocolitica epidemic: a follow up study.

Authors:  H Lindholm; R Visakorpi
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

Review 2.  B27 positive diseases versus B27 negative diseases.

Authors:  A Linssen; T E Feltkamp
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

3.  Complement activation and HLA-B27.

Authors:  S Meri; J Partanen; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

4.  Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.

Authors:  R Bucknall; M Leirisalo-Repo; O Laitinen; J V Jones
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

5.  Acute anterior uveitis after yersinia infection.

Authors:  L Mattila; K Granfors; A Toivanen
Journal:  Br J Ophthalmol       Date:  1982-03       Impact factor: 4.638

6.  Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.

Authors:  C T Pease; J N Fordham; H L Currey
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

7.  Tachyarrhythmia in yersinia arthritis.

Authors:  T Lenz; F Keller
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

8.  Demonstration of antibodies against Yersinia enterocolitica lipopolysaccharide in human sera by enzyme-linked immunosorbent assay.

Authors:  M Gripenberg; A Nissinen; E Väisänen; E Linder
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

9.  Clinical and serological studies in patients with Campylobacter fetus ssp. jejuni infection: I. Clinical findings.

Authors:  T Pitkänen; T Pettersson; A Pönkä; T U Kosunen
Journal:  Infection       Date:  1981       Impact factor: 3.553

10.  Antibody- and complement-dependent cell injury assayed by 51Cr release from human peripheral blood mononuclear cells pretreated with lipopolysaccharide.

Authors:  H Repo; M Leirisalo-Repo; M Nurminen; P H Mäkelä
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.